MA46415A - Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques - Google Patents

Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques

Info

Publication number
MA46415A
MA46415A MA046415A MA46415A MA46415A MA 46415 A MA46415 A MA 46415A MA 046415 A MA046415 A MA 046415A MA 46415 A MA46415 A MA 46415A MA 46415 A MA46415 A MA 46415A
Authority
MA
Morocco
Prior art keywords
complex
treatment
compositions
ophthalmic
dermatological diseases
Prior art date
Application number
MA046415A
Other languages
English (en)
Other versions
MA46415B1 (fr
Inventor
Cesare Busetti
Daniela Zelaschi
Original Assignee
Ntc S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ntc S R L filed Critical Ntc S R L
Publication of MA46415A publication Critical patent/MA46415A/fr
Publication of MA46415B1 publication Critical patent/MA46415B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un complexe de terpinène-4-ol et d'un polymère d'acide hyaluronique réticulé, en particulier avec de l'urée, et des compositions le contenant. L'invention concerne en outre l'utilisation du complexe, ou de compositions le contenant, dans l'hygiène de la zone périoculaire, et dans le traitement de la blépharite, de l'acné, de la rosacée, de la conjonctivite aiguë ou chronique, ou des infestations provoquées par les acariens, en particulier par les acariens demodexor et cheyletiella.
MA46415A 2016-09-26 2017-09-26 Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques MA46415B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102016000096125A IT201600096125A1 (it) 2016-09-26 2016-09-26 Complesso e composizioni per il trattamento di affezioni oculari e cutanee
PCT/EP2017/074337 WO2018055194A1 (fr) 2016-09-26 2017-09-26 Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques

Publications (2)

Publication Number Publication Date
MA46415A true MA46415A (fr) 2019-07-31
MA46415B1 MA46415B1 (fr) 2021-02-26

Family

ID=57960613

Family Applications (1)

Application Number Title Priority Date Filing Date
MA46415A MA46415B1 (fr) 2016-09-26 2017-09-26 Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques

Country Status (7)

Country Link
EP (1) EP3515409B1 (fr)
DK (1) DK3515409T3 (fr)
ES (1) ES2841940T3 (fr)
IT (1) IT201600096125A1 (fr)
MA (1) MA46415B1 (fr)
PL (1) PL3515409T3 (fr)
WO (1) WO2018055194A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3806919B1 (fr) * 2018-06-15 2024-05-15 Croma-Pharma GmbH Composition d'hydrogel comprenant un polymère réticulé
IT201800008192A1 (it) * 2018-08-27 2020-02-27 Ira St Ricerche Applicate Spa Microsfere di acido ialuronico reticolato con urea e contenenti almeno un agente attivo o farmaco

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631242A (en) * 1993-08-04 1997-05-20 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis
ITMI20030195A1 (it) * 2003-02-06 2004-08-07 Bsd Bioscience Dev Snc Di O Mini C E Zucc Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
US20090036554A1 (en) * 2007-08-01 2009-02-05 Burke Susan E Ophthalmic compositions comprising a terpene compound
US8128968B2 (en) 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
ITMI20131193A1 (it) * 2013-07-16 2015-01-17 Ira Srl Acido ialuronico reticolato, processo per la sua preparazione ed applicazioni in ambito estetico

Also Published As

Publication number Publication date
EP3515409B1 (fr) 2020-10-28
WO2018055194A1 (fr) 2018-03-29
IT201600096125A1 (it) 2018-03-26
MA46415B1 (fr) 2021-02-26
ES2841940T3 (es) 2021-07-12
DK3515409T3 (da) 2021-01-11
EP3515409A1 (fr) 2019-07-31
PL3515409T3 (pl) 2021-05-31

Similar Documents

Publication Publication Date Title
MA35365B1 (fr) Pyrimidines annelées substituées et leur utilisation
EA201791866A1 (ru) Бициклические гетероциклы в качестве ингибиторов fgfr
MA42376B1 (fr) Dérivés d'oxopyridine substitués
MA34248B1 (fr) 5-fluoro-1h-pyrazolopyridines substituées et leur utilisation
EA201390826A1 (ru) ПИРИМИДИНОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ИЛИ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ Lp-PLA
MA41238B1 (fr) Dérivés 5-[(pipérazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione en tant qu'inhibiteurs d'adamts pour le traitement de l'ostéoarthrit
MA38349A1 (fr) Œstra-1,3,5(10),16-tétraéno-3-carboxamide pour inhiber la 17-bêta-hydroxystéroïde déshydrogénase (akr1c3)
TN2015000328A1 (en) Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
MA44948A1 (fr) Inhibiteurs de bace 1
MA40283A (fr) Aptamères spécifiques du récepteur tlr-4 et leurs utilisations
MA34545B1 (fr) Co-cristaux et sels d'inhibiteurs de ccr3
CA3010708A1 (fr) Procedes d'administration d'hepcidine
MA38925B1 (fr) Dérivés de phénylalanine substitués
EA201891608A1 (ru) Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана
MA38296B2 (fr) Peptides inhibiteurs sélectifs de nox-1 et leurs utilisations
MA46415B1 (fr) Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques
MA35457B1 (fr) Nouvelles formulations de pyriméthanil et leur utilisations dans le traitement des cultures
MA46235B1 (fr) 1-aryl-naphtyridin-3-ylcarboxamides substitués en position 7 et leur utilisation
BR112015022849A2 (pt) sais de adição de base de nitroxolina e usos dos mesmos
MA42455B1 (fr) Nouveau composé hétérocyclique, procédé de préparation associé et composition pharmaceutique le comprenant
MA40844A (fr) Compositions pharmaceutiques à action prolongée pour l'hépatite c
MA39406A1 (fr) Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline
MA51278A (fr) Utilisation d'un extrait végétal en tant qu'agent actif dans le traitement de maladies dermatologiques
EA201990550A1 (ru) Офтальмологический препарат, включающий азоловое соединение
FR3018045B1 (fr) Composition ophtalmique remanente, notamment pour le traitement de la secheresse oculaire